This is a preview. View original post on this site
The Drug Enforcement Administration (DEA) announced rules that allowed physicians to prescribe controlled substances via telemedicine. They took effect on October 6, 2020, and intended to expand access to controlled substances for patients who were unable to obtain them in person due to the COVID-19 pandemic. They will formally end May 11, 2023.
What unfolded in the following year caused quite a stir, with entrepreneurs pouncing on the opportunity.
Under the new rules, physicians could prescribe controlled substances to patients via telemedicine without requiring an in-person exam, even allowing prescribing by out-of-state physicians. This is a significant change